AWARD OUTCOME
What happened
The Clatterbridge Cancer Centre NHS Foundation Trust published a direct-award transparency notice for CAR-T therapies Yescarta and Tecartus. The notice names GILEAD SCIENCES LTD as supplier and reports a £893,953 gross value for award 1, but that award is marked pending and a future signature milestone was scheduled for 19 October 2026.
Published outcomeA direct award to GILEAD SCIENCES LTD is reported for lot 1, subject to the pending award status shown in the source.
Market significanceThis is a single-supplier direct procurement of specialist CAR-T pharmaceutical products commissioned by NHS England.
AWARDED SUPPLIERS AND LOTS
1 supplier record analysed
GILEAD SCIENCES LTD
99% confidenceAward 1 · Lots 1 · 893953 GBP · pending
View supporting evidence
Award 1 names GILEAD SCIENCES LTD as supplier, relates to lot 1, has pending status, and reports £893,953 gross. Supplier identity is verified against company number 02543818.
LIFECYCLE
Award or contract stage
Published notice
99% confidenceTransparency notice published 19 October 2026
View supporting evidence
Award document 098474-2026 is described as a Transparency notice on Find a Tender and dated 2026-10-19T13:18:06+01:00.
Award status
99% confidencePending
View supporting evidence
Award 1 has status 'pending'.
Signature milestone
99% confidenceScheduled for 19 October 2026
View supporting evidence
Award 1 milestone type futureSignatureDate has dueDate 2026-10-19T23:59:59+01:00 and status scheduled.
Contract conclusion
98% confidenceNot confirmed by the supplied award record
View supporting evidence
The stated award is pending and the supplied data does not explicitly confirm signature or concluded-contract status.
VALUES
Published values explained
Reported award value
99% confidence£893,953 gross
View supporting evidence
Award 1 value states amountGross 893953, amount 893953, currency GBP.
Value allocation
97% confidenceAllocated to award 1; no separate lot value published
View supporting evidence
The value is recorded at award level for award 1, which relates to lot 1; the lot record has no value amount.
TIMELINE
Procurement timeline
Notice publication
99% confidence19 October 2026, 13:18 BST
View supporting evidence
Award notice document datePublished is 2026-10-19T13:18:06+01:00.
Scheduled signature date
99% confidence19 October 2026
View supporting evidence
The futureSignatureDate milestone is due by 2026-10-19T23:59:59+01:00.
Reported contract period
98% confidence19 October 2026 only
View supporting evidence
Award 1 contractPeriod runs from 2026-10-19T00:00:00+01:00 to 2026-10-19T23:59:59+01:00.
SCOPE
What was awarded
Requirement
99% confidenceCAR-T therapy: Yescarta and Tecartus
View supporting evidence
The procurement title and description state it covers Yescarta and Tecartus, identified as axicabtagene ciloleucel and brexucabtagene autoleucel.
Procurement category
99% confidenceGoods — pharmaceutical products
View supporting evidence
Award 1 mainProcurementCategory is goods; its item has CPV 33600000, Pharmaceutical products.
Lot structure
99% confidenceOne lot reported (lot 1)
View supporting evidence
Tender data lists lot 1 and award 1 relates to lot 1.
Delivery region
97% confidenceUKD72
View supporting evidence
Award item delivery address specifies region UKD72, United Kingdom.
PROCEDURE
Procedure and competition
Procedure
99% confidenceDirect award
View supporting evidence
Tender procurementMethod is direct and procurementMethodDetails is Direct award.
Direct-award rationale
99% confidenceCommissioned by NHS England with a single supplier for the service
View supporting evidence
The published procurementMethodRationale states: 'Commissioned by NHS England with single supplier only for this service.'
Rationale classification
98% confidenceSingle supplier for technical reasons
View supporting evidence
Tender rationale classification is singleSuppliersTechnicalReasons.
Competition information
99% confidenceNot supplied in the published notice
View supporting evidence
No bid count, bidder list, evaluation results, or scoring information is supplied.
CONTRACT TERMS
Published contract terms
Reported period
98% confidence19 October 2026 to 19 October 2026
View supporting evidence
Award 1 contractPeriod gives those start and end timestamps.
Contract status
99% confidenceNot confirmed as signed or active
View supporting evidence
Award 1 is pending and signature is a scheduled future milestone.
Extension and renewal terms
99% confidenceNot supplied in the published notice
View supporting evidence
No extension or renewal provisions are included in the supplied data.
COMMERCIAL VIEW
Commercial observations
Market route
99% confidenceSingle-supplier direct-award route
View supporting evidence
The notice records a direct award and states NHS England commissioned the service with a single supplier only.
Commercial certainty
99% confidenceLimited until award signature/conclusion is confirmed
View supporting evidence
The reported £893,953 award remains pending and has a scheduled future signature milestone.
DATA QUALITY
Gaps and source limitations
Conflicting award records
99% confidenceA second award record (award 2) is marked active but has no value, date, supplier allocation in its award row, or supporting award detail in the supplied OCDS award data.
View supporting evidence
Top-level awards include award 2 with status active and no value; detailed tender awards include only award 1, marked pending.
Status interpretation
99% confidenceThe reported supplier and value are evidenced only for pending award 1.
View supporting evidence
Detailed award 1 names the supplier and value; no corresponding detailed award 2 information is supplied.
Lot detail
99% confidenceLot 1 has no published title, description, or value.
View supporting evidence
Lot 1 fields for title, description and value are null.
Published information gaps
99% confidenceInformation not supplied in the published notice includes award date, bid counts, evaluation details, pricing breakdown, and extension or renewal terms.
View supporting evidence
These fields are absent from the supplied notice data.
SOURCE DATA LIMITATIONS
Information not supplied in the published notice
- Award data is inconsistent: detailed award 1 is pending, while a separate top-level award 2 is marked active without supporting supplier, value or detailed award information. This analysis does not treat the procurement as a signed or active contract.
- The stated £893,953 is reported for pending award 1 and is not evidence of a concluded contract value.
- No award date, bid count, bidder information, evaluation results, scores, pricing breakdown, lot title, lot description, individual lot value, extension terms or renewal terms were supplied.
- The reported one-day contract period may reflect the source record, but no explanation is supplied.
MARKET THEMES
Relevant award themes
Clatterbridge Cancer Centre NHS Foundation TrustGILEAD SCIENCES LTDCAR-T therapyYescartaTecartusdirect awardpharmaceutical products
COMMON QUESTIONS
About this award
Who is named as supplier?
GILEAD SCIENCES LTD, verified against company number 02543818, is named for pending award 1.
What is the reported value?
The notice reports a gross value of £893,953 for pending award 1.
Has the contract been confirmed as signed?
No. The detailed award is pending and shows a signature milestone scheduled for 19 October 2026.
Why was a direct award used?
The notice states that NHS England commissioned the service with a single supplier only, and classifies the rationale as single supplier for technical reasons.
ProcuraAxis award analysis supplements, but does not replace, the official award notice, contract data or procurement documents. “Awarded” does not by itself prove that a contract has been signed.